T2 Biosystems, Inc. (TTOO)

T2 Biosystems Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2.08	15.69	10.33	22.25	16.79	11.03
Short-Term Investments	-	-	-	10	25.4	-
Cash & Short-Term Investments	2.08	15.69	10.33	32.24	42.19	11.03
Cash Growth	-91.44%	51.89%	-67.96%	-23.58%	282.39%	-78.28%
Receivables	2.03	1.42	2.16	5.13	5.1	2.83
Inventory	3.83	4.82	4.29	3.91	3.64	3.6
Prepaid Expenses	1.85	3.26	2.58	3.01	2.56	1.44
Other Current Assets	-	-	-	0.1	0.1	-
Total Current Assets	9.79	25.19	19.36	44.39	53.58	18.9
Property, Plant & Equipment	7.75	9.05	13.27	14.44	14.81	9.21
Long-Term Investments	-	-	-	-	10	-
Long-Term Deferred Charges	-	-	-	-	0.1	-
Other Long-Term Assets	0.55	0.56	1.69	1.7	0.59	0.39
Total Assets	18.08	34.8	34.33	60.54	79.08	28.49

Liabilities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Accounts Payable	4.21	1.53	1.3	2.83	2.06	3.75
Accrued Expenses	5.93	9.71	7.27	7.16	6.36	9.22
Current Portion of Long-Term Debt	11.92	41.28	-	-	-	45.33
Current Portion of Leases	1.72	1.62	1.35	1.17	1.15	1.98
Current Unearned Revenue	0.23	0.22	0.17	0.52	0.23	0.29
Other Current Liabilities	0.41	1.79	0.04	-	-	-
Total Current Liabilities	24.44	56.15	10.13	11.69	9.8	60.57
Long-Term Debt	-	-	49.65	47.79	46.25	-
Long-Term Leases	5.3	6.6	8.21	9.36	10.53	1.87
Long-Term Unearned Revenue	0.06	0.08	0.05	0.03	0.42	0.05
Other Long-Term Liabilities	-	-	5.94	4.58	3.35	-
Total Liabilities	29.79	62.83	73.98	73.44	70.35	62.49

Shareholders' Equity

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Common Stock	0.02	0	-	0	0.15	0.05
Additional Paid-In Capital	605.18	556.26	494.56	459.31	431.54	342.12
Retained Earnings	-616.91	-584.3	-534.22	-472.22	-422.98	-376.18
Comprehensive Income & Other	-	-	-	-0	0.01	-
Total Common Equity	-11.71	-28.04	-39.66	-12.9	8.73	-34.01
Shareholders' Equity	-11.71	-28.04	-39.66	-12.9	8.73	-34.01
Total Liabilities & Equity	18.08	34.8	34.33	60.54	79.08	28.49

Additional Metrics

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total Debt	18.94	49.5	59.22	58.32	57.93	49.18
Net Cash (Debt)	-16.86	-33.81	-48.89	-26.08	-5.74	-38.15
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.60	-12.95	-958.53	-820.91	-236.46	-
Filing Date Shares Outstanding	21.04	5.51	0.2	0.03	0.03	0.02
Total Common Shares Outstanding	18.76	4.06	0.08	0.03	0.03	0.01
Working Capital	-14.65	-30.96	9.23	32.71	43.78	-41.68
Book Value Per Share	-0.62	-6.91	-513.90	-387.71	294.64	-3356.86
Tangible Book Value	-11.71	-28.04	-39.66	-12.9	8.73	-34.01
Tangible Book Value Per Share	-0.62	-6.91	-513.90	-387.71	294.64	-3356.86
Machinery	12.07	12.1	13.54	14.59	11.84	13.18
Construction In Progress	0.03	0.02	0.69	0.51	1.73	1.64
Leasehold Improvements	3.61	3.61	3.78	3.77	3.69	3.5

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 6, 2026

Data Sources Report a data error